GlassScriptPhysician profile
Glenn L Morgan
NPI 1235240870
$6,742.86
in general payments reported to CMS, 2019-2025
18 companies · $2,000 in 2025
The $2,000 reported for 2025 was more than what 90% of Gynecology providers received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $597 · 2020: $334 · 2021: $322 · 2022: $324 · 2023: $287 · 2024: $2,879 · 2025: $2,000.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,800 · Food and Beverage: $366.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,800.00 |
| Food and Beverage | $366.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $4,815.02 | 2024-2025 | Bovine Collagen |
| Daiichi Sankyo INC. | $396.46 | 2019-2022 | |
| Abbvie INC. | $328.07 | 2019-2022 | |
| Shield Therapeutics INC | $170.85 | 2023-2024 | Accrufer |
| Hologic Sales and Service, LLC | $150.77 | 2019-2023 | Thinprep 2000 Processor |
| Exeltis, USA INC. | $149.07 | 2019-2021 | |
| Mission Pharmacal Company | $142.91 | 2019-2023 | Citranatal |
| Astellas Pharma US INC | $135.85 | 2022-2023 | Veozah, Myrbetriq |
| Ascend Therapeutics US, LLC | $109.19 | 2019 | |
| Mayne Pharma Commercial LLC | $106.10 | 2022 | |
| Myovant Sciences INC. | $55.70 | 2021 | |
| Roche Diagnostics Corporation | $39.09 | 2019 | |
| Ethicon US, LLC | $31.36 | 2022 | |
| Therapeuticsmd, INC. | $26.68 | 2021 | |
| Organon LLC | $24.86 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $23.36 | 2019 | |
| Pfizer INC. | $23.04 | 2024 | |
| Novo Nordisk INC | $14.48 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Glenn Morgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.